These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30644699)

  • 1. Expression Analysis of BDNF Gene and BDNF-AS Long Noncoding RNA in Whole Blood Samples of Multiple Sclerosis Patients: Not Always a Negative Correlation between Them.
    Gharzi V; Gangi M; Sayad A; Mazdeh M; Arsang-Jang S; Taheri M
    Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):548-556. PubMed ID: 30644699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression analysis of long non-coding RNAs and their target genes in multiple sclerosis patients.
    Ganji M; Sayad A; Omrani MD; Arsang-Jang S; Mazdeh M; Taheri M
    Neurol Sci; 2019 Apr; 40(4):801-811. PubMed ID: 30680474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression Analysis of Long Non-coding RNAs in the Blood of Multiple Sclerosis Patients.
    Eftekharian MM; Ghafouri-Fard S; Soudyab M; Omrani MD; Rahimi M; Sayad A; Komaki A; Mazdeh M; Taheri M
    J Mol Neurosci; 2017 Dec; 63(3-4):333-341. PubMed ID: 28967047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study.
    Sağır F; Ersoy Tunalı N; Tombul T; Koral G; Çırak S; Yılmaz V; Türkoğlu R; Tüzün E
    Genet Test Mol Biomarkers; 2021 Nov; 25(11):720-726. PubMed ID: 34788141
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis.
    Liguori M; Fera F; Gioia MC; Valentino P; Manna I; Condino F; Cerasa A; La Russa A; Clodomiro A; Paolillo A; Nisticò R; Vercillo L; Cittadella R; Quattrone A
    Genes Brain Behav; 2007 Mar; 6(2):177-83. PubMed ID: 16740142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNAs associated with multiple sclerosis expressed in the Th1 cell lineage.
    Hosseini A; Teimuri S; Ehsani M; Rasa SMM; Etemadifar M; Nasr Esfahani MH; Megraw TL; Ghaedi K
    J Cell Physiol; 2019 Dec; 234(12):22153-22162. PubMed ID: 31066039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal observation of brain-derived neurotrophic factor mRNA levels in patients with relapsing-remitting multiple sclerosis.
    Liguori M; Fera F; Patitucci A; Manna I; Condino F; Valentino P; Telarico P; Cerasa A; Gioia MC; di Palma G; Quattrone A
    Brain Res; 2009 Feb; 1256():123-8. PubMed ID: 19071096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of NF-κB-Associated lncRNAs in Multiple Sclerosis Patients.
    Safa A; Arsang-Jang S; Taheri M; Omrani MD; Ghafouri-Fard S
    J Mol Neurosci; 2021 Jan; 71(1):80-88. PubMed ID: 32613554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Biomarker and Therapeutic LncRNAs in Multiple Sclerosis Through Targeting Memory B Cells.
    Ghoveud E; Teimuri S; Vatandoost J; Hosseini A; Ghaedi K; Etemadifar M; Nasr Esfahani MH; Megraw TL
    Neuromolecular Med; 2020 Mar; 22(1):111-120. PubMed ID: 31576494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of OIP5-AS1/HUR1 to discover new potential biomarkers and therapeutic targets in multiple sclerosis.
    Gharesouran J; Taheri M; Sayad A; Mazdeh M; Omrani MD
    J Cell Physiol; 2019 Aug; 234(10):17351-17360. PubMed ID: 30815864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients.
    Nazdik MK; Taheri M; Sajjadi E; Arsang-Jang S; Koohpar ZK; Inoko H; Sayad A
    Hum Antibodies; 2016; 24(3-4):65-70. PubMed ID: 27689613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Putative Association of TOB1-AS1 Long Non-coding RNA with Immune Tolerance: A Study on Multiple Sclerosis Patients.
    Dehghanzad R; Pahlevan Kakhki M; Alikhah A; Sahraian MA; Behmanesh M
    Neuromolecular Med; 2020 Mar; 22(1):100-110. PubMed ID: 31482275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse Relation between MxA Gene Expression and Age in Multiple Sclerosis Patients Reveals a Gender Difference in Response to Interferon Therapy.
    Taheri M; Mirinezhad M; Omrani MD; Sajjadi E; Inoko H; Sayad A
    Iran J Allergy Asthma Immunol; 2017 Feb; 16(1):21-27. PubMed ID: 28417621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis.
    Tongiorgi E; Sartori A; Baj G; Bratina A; Di Cola F; Zorzon M; Pizzolato G
    J Neurol Sci; 2012 Sep; 320(1-2):161-5. PubMed ID: 22836016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of LncRNA BDNF-AS attenuates Aβ
    Guo CC; Jiao CH; Gao ZM
    Neurol Res; 2018 Sep; 40(9):795-804. PubMed ID: 29902125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression Analysis of Long Non-coding RNA Lnc-DC in HLA-DRB1*15:01-Negative Patients with Multiple Sclerosis: A Probable Cause for Gender Differences in Multiple Sclerosis Susceptibility?
    Bahrami T; Taheri M; Javadi S; Omrani MD; Karimipour M
    J Mol Neurosci; 2021 Apr; 71(4):821-825. PubMed ID: 32951137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: an imaging genetic study.
    Cerasa A; Tongiorgi E; Fera F; Gioia MC; Valentino P; Liguori M; Manna I; Zito G; Passamonti L; Nisticò R; Quattrone A
    Behav Brain Res; 2010 Mar; 207(2):377-86. PubMed ID: 19874854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression analysis of NF-κB-associated long noncoding RNAs in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients.
    Soltanmoradi S; Tavakolpour V; Moghadasi AN; Kouhkan F
    J Neuroimmunol; 2021 Jul; 356():577602. PubMed ID: 33979709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor downregulation in gastric cancer.
    Esfandi F; Bouraghi H; Glassy MC; Taheri M; Kahaei MS; Kholghi Oskooei V; Ghafouri-Fard S
    J Cell Biochem; 2019 Oct; 120(10):17831-17837. PubMed ID: 31172586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-cell BDNF expression in treatment-naïve relapsing-remitting multiple sclerosis patients and following one year of immunomodulation therapy.
    Kalinowska-Łyszczarz A; Pawlak MA; Wyciszkiewicz A; Osztynowicz K; Kozubski W; Michalak S
    Neurol Neurochir Pol; 2018 Aug; 52(4):483-489. PubMed ID: 29643001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.